Care Delivery

This channel includes news on cardiovascular care delivery, including how patients are diagnosed and treated, cardiac care guidelines, policies or legislation impacting patient care, device recalls that may impact patient care, and cardiology practice management.

Thumbnail

Johnson & Johnson pauses use of FDA-approved PFA system to investigate patient complications

Johnson & Johnson MedTech's Varipulse PFA system has been linked to multiple reports of "neurovascular events" in patients. The company hopes to share more information in the days ahead. 

doctor patient elderly check up hospital

Surgery outperforms PCI in NSTEMI patients with multivessel CAD

CABG was associated with a 41% lower risk of long-term mortality than PCI in a new study of more than 57,000 patients. The full analysis was published in European Heart Journal.

Withings, a French medtech company known for its remote monitoring devices, has multiple new services on display at CES 2025.

CES 2025: Cardiologist check-ups, AI-powered smart mirrors coming to heart patients’ homes

Healthcare companies from all over the world are showing off their newest cardiovascular offerings at CES 2025 in Las Vegas.

Surgeons Operating On Patient

Radial secondary access during TAVR limits complications

Radial access is already the primary choice for many cardiologists performing PCI due to a lower risk of complications. The same appears to be true for secondary access during TAVR.

artificial intelligence AI infrastructure

Industry Watcher’s Digest

New Year’s Day brought the go-live for California’s new law forbidding the use of AI to deny health insurance claims. 

FDA AI enabled medical devices approval clearance

FDA to hopeful marketers of AI-equipped medical devices: Think beyond your initial approval

Some FDA-approved medical devices age more safely than others. That’s no less true of AI-enabled technologies than of any others. The agency spells out the ramifications in draft guidance issued this week. 

Semaglutide linked to ‘significant and consistent’ benefits for heart bypass surgery patients

The popular GLP-1 receptor agonist appears to help limit adverse events and new-onset diabetes in patients with a history of CABG. Researchers shared the full study in the Journal of the American College of Cardiology.

From left to right: Sunita Ferns, MD; Mark Plunkett, MD; Harma Turbendian, MD. Images courtesy of OSF Healthcare.

History made: Young child treated with new heart device for very first time

A care team in Illinois has performed the first heart procedure of its kind on a two-year-old patient diagnosed with Brugada syndrome.